LYRA
NASDAQ · Pharmaceuticals
Lyra Therapeutics Inc
$0.40
-0.08 (-15.79%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,400.0% upside
Low Target
$9.32
Average Target
$14.00
High Target
$16.42
Current Price
$0.40
Current
$0.40
$0.40
Target
$14.00
$14.00
$9.32
$14.00 avg
$16.42
Scenario Analysis
Bear Case
$9.32
2,230.0%
Low target
Base Case
$14.00
+3,400.0%
Avg target
Bull Case
$16.42
+4,005.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$14.00
+60.0% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-1.57
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals